Expanding The Opioid Use Disorder Medication Treatment Workforce in Rural Communities Through The RCORP Initiative

Key findings from this study suggest that the RCORP initiative may have played an important role in expanding the supply of buprenorphine prescribers nationally.  While the impacts of the removal of the DEA-waiver since 2023 have not yet been identified, counties where RCORP grantees operated showed larger increases in the number of DEA-waivered clinicians over the study period compared to non-RCORP counties, amounting to an average of almost four more clinicians per 100,000 than non-RCORP counties.

The post Expanding The Opioid Use Disorder Medication Treatment Workforce in Rural Communities Through The RCORP Initiative appeared first on Pennsylvania Office of Rural Health.